KPV exerts its protective effects primarily through the modulation of the MAPK/NF-κB signaling pathways, inhibiting the activation of NF-κB and reducing pro-inflammatory cytokine secretion, such as IL-1β. It also mitigates oxidative stress by decreasing reactive oxygen species (ROS) production, which in turn prevents the activation of caspase-1 and apoptosis-related proteins, thereby promoting cell survival and reducing inflammation. While the precise receptors involved in KPV's action are not fully elucidated, its effects are linked to the modulation of melanocortin receptors and downstream signaling pathways in inflammatory cells.